LLY Eli Lilly and Co
- 952.740
- -1.430-0.15%
- 949.900
- -2.840-0.30%
Eli Lilly and Co News
Eli Lilly Alzheimer's Drug Set to Face Same Fate as Biogen's in U.K.: Report
Express News | U.S. CDC Says Free At Home, Covid 19 Test Delivery Programs Will Reopen In Late September
Exploring The Competitive Space: Eli Lilly Versus Industry Peers In Pharmaceuticals
On August 22, the top 20 trading volume in the US stock market: Apple will allow European Union users to delete default applications such as Safari.
Nvidia ranked first in trading volume on Thursday, with a 3.70% decrease and a turnover of $46.925 billion. Former Google CEO Schmidt recently stated that major technology companies are planning increasingly large investments in Nvidia-based artificial intelligence datacenters, with construction costs potentially reaching $300 billion. Schmidt said, "I am talking to big companies, and these big companies tell me that they need $20 billion, $50 billion, $100 billion - very, very difficult." Schmidt stated that a large part of this expenditure will flow to Nvidia, whose datacenter AI chips dominate the market.
Eli Lilly and Co Options Spot-On: On August 22nd, 76,149 Contracts Were Traded, With 312.6K Open Interest
Form 144 | Eli Lilly and Co(LLY.US) 10% Stockholder Proposes to Sell 204.67 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Aug 22, $Eli Lilly and Co(LLY.US)$ 10% Stockholder LILLY ENDOWMENT INC intends to sell 215K shares of its common stock on Aug 22, with a total market value of approximately $20
GLP-1s Partly to Blame for Spike in Health Insurance Costs in 2025
Check Out What Whales Are Doing With LLY
In One Chart | Wall Street Eyes New Sectors for the Next Stock Market Surge
Least Shorted S&P 500 Stocks in July
Express News | Oblique Therapeutics Has Entered a Research Collaboration Agreement With Eli Lilly and Company to Apply the Abiprot® Technology to Generate Antibodies to a High-Value Target
Generic Weight-Loss Drugs Won't Come for Years -- Barrons.com
Lilly to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
Wegovy Now Available Through Sesame's $249 Monthly Compounded Program Despite Supply Shortages
Morgan Stanley's 20 Top Stock Picks
Novo Nordisk Vs. Eli Lilly: Beyond The Weight-Loss Drug Battle
BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,101
Asia Mixed, European Markets Advance; Gold Stays Near All Time High While Dollar Gains - Global Markets Today While US Slept
Trending Tickers: JD.com, Netflix, Eli Lilly and Mobico
Eli Lilly and Co. reached a new historical high! The 'miracle weight loss drug' almost 'prevents' diabetes, but...
The medicine cannot be stopped.
Analysis
Price Target
No Data
